SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is capturing community attention as supporters push for organic growth and long-term development while frequently highlighting the project's accessibility on platforms like Coinbase and Phantom wallet. Investors are actively discussing the anticipation of upcoming airdrops and chart visibility, positioning the coin as a grassroots movement focused on building a dedicated base.

Frontera Energy Corp. engages in the exploration, development, production, transportation, storage, and sale of oil and natural gas. It operates interests in exploration and production blocks in Colombia, Ecuador and Guyana, and pipeline and port facilities in Colombia. The company was founded on April 10, 1985 and is headquartered in Calgary, Canada.

Frontera Energy Corporation - Ordinary Shares New

Frontera Energy is trending as investors monitor the company's strategic pivot toward infrastructure assets and its ongoing legal and commercial efforts in Guyana. The community is heavily focused on the potential value of the Puerto Baha terminal and the long-term arbitration prospects for the Corentyne block, which are viewed by many as a high-stakes, unpriced optionality.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging as investors debate its role as a satirical parody of traditional crypto, drawing significant attention to its long history and community-driven lore. The asset is trending due to excitement over its unique origin story, with community members actively discussing its potential for mass adoption and its movement on the Solana blockchain.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is currently trending as investors focus on its potential to flip key technical resistance levels while reacting to broader market optimism sparked by a ceasefire in the Middle East. The community is actively debating the token's institutional adoption, its performance relative to Bitcoin, and whether the current price action signals the start of a sustained breakout.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending as investors debate its long-term utility against market volatility, with community sentiment split between frustration over price action and excitement regarding institutional adoption and upcoming network upgrades. Discussions are heavily focused on its role in real-world asset tokenization and cross-border payments, fueling a divide between those accumulating for the long haul and those fearing further downside risks.

WorldFinancial

WLFI is currently a focal point of intense market speculation and debate, with community members aggressively debating its future as supporters highlight upcoming events at Mar-a-Lago and potential institutional adoption, while critics point to ongoing regulatory investigations and allegations of fraud. Investors remain sharply divided, with bulls betting on a potential breakout driven by low-float dynamics and Trump-affiliated catalysts, while bears warn of a pump-and-dump scheme that could lead to significant downside.

NKN is building the largest blockchain for network sharing.

New Kind of Network

NKN is currently experiencing significant market volatility and trending status as investors speculate on potential partnerships, mergers, and recovery momentum. The community is actively debating whether the current price action represents a genuine reversal or a pump-and-dump scheme, with many watching for breakout patterns similar to other small-cap assets.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending as investors focus on its role in critical subsea defense infrastructure, specifically following a massive 615 million dollar acquisition of Covelya Group that significantly scales its global operations. Community sentiment remains largely bullish, with many viewing recent volatility and pullbacks as opportunities to build long-term positions ahead of a potential major exchange uplisting and continued government spending on autonomous underwater systems.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

GlobalFoundries is currently surging following a strong earnings beat, encouraging guidance, and a new share buyback program, with the community highlighting its strategic importance in securing U.S. domestic semiconductor capacity. Investors are actively discussing recent multi-billion-dollar manufacturing partnerships, substantial CHIPS Act funding, and its expanded role in AI and advanced packaging.

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Journey Medical Corp is generating significant investor buzz as community members closely monitor its Q1 performance and the broader rollout of its rosacea drug, Emrosi, following reports of improved insurance coverage and favorable formulary additions. While some investors express frustration over stock volatility and limited communication from management, many are actively accumulating shares in anticipation of a potential revenue inflection and the strengthening of the company's competitive position.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Praxis Precision Medicines (NASDAQ:PRAX) Upgraded to Strong-Buy at Raymond James Financial

Raymond James Financial raised Praxis Precision Medicines to a "strong-buy" rating in a report on Thursday...

Raymond James Financial Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX)

Raymond James Financial began coverage on shares of Praxis Precision Medicines in a research note on Friday. They issued a "strong-buy" rating and a $815.00 price target on the stock...

JPMorgan Chase & Co. Grows Position in Praxis Precision Medicines, Inc. $PRAX

JPMorgan Chase & Co. raised its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 88.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,208 shares of the compan...

HC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)

HC Wainwright reaffirmed a "buy" rating and issued a $1,245.00 target price on shares of Praxis Precision Medicines in a research note on Tuesday...

BTIG Research Reaffirms "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX)

BTIG Research reissued a "buy" rating and set a $843.00 target price on shares of Praxis Precision Medicines in a research report on Monday...

Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial

Praxis Precision Medicines shares are trading higher Monday after it announced positive results from the EMBRAVE Part A Trial of Elsunersen.read more...

Aberdeen Group plc Takes $39.79 Million Position in Praxis Precision Medicines, Inc. $PRAX

Aberdeen Group plc bought a new position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with...

SG Americas Securities LLC Cuts Position in Praxis Precision Medicines, Inc. $PRAX

SG Americas Securities LLC lessened its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 26.2% during the fourth quarter, according to the company in its most recent Form...

Praxis Precision Medicines (NASDAQ:PRAX) Trading Up 13.4%  - Time to Buy?

Praxis Precision Medicines (NASDAQ:PRAX) Trading 13.4% Higher - Time to Buy...

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nineteen ratings firms that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, one...

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$3.57	--	--	N/A
Q4 '25	-$3.10	-$3.50	-12.87%	MISSED
Q3 '25	-$3.44	-$3.36	2.39%	BEAT
Q2 '25	-$3.25	-$3.31	-1.94%	MISSED
Q1 '25	-$3.21	-$3.29	-2.58%	MISSED

PRAX
Praxis Precision Medicines Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest PRAX News

PRAXPraxis Precision Medicines Inc